top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Antiviral Agents
Antiviral Agents
Autore Adamson Catherine
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 online resource (386 p.)
Soggetto topico Biology, life sciences
Research and information: general
Soggetto non controllato acteoside
acute/latent infection
acyclovir
adoptive cell therapy
antipsychotic drug
antiviral
antiviral activity
antiviral agent
antiviral agents
antiviral drug
antiviral effect
antiviral inhibitor
antiviral strategies
branched peptides
brevilin A
Burkitt lymphoma cells
C-FRA
cathelicidins
central nervous system
chemical footprinting
Clerodendrum trichotomum
clozapine
combination antiretroviral therapy (cART)
congenital infection
coxsackievirus B4
CRISPR/Cas
cytomegalovirus
defensins
dried blood spots
dried plasma spots
drug discovery
endocytosis
enteroviruses
epigallocatechin gallate
Epstein-Barr virus
Ethiopia
flavivirus
flavonoids
fluoxetine
furin inhibitor
ganciclovir
genistein
ginsenoside Rg1
glycosphingolipids
HCMV vaccine
hemagglutinin (HA)
heparan sulfate
hepatitis C virus
hepcidins
herpes B virus
herpes viruses
herpesvirus
HIV
human antimicrobial peptides
human immunodeficiency virus
ie-1 gene
IE1
IE2
immediate-early
influenza A virus
influenza A virus (IAV)
Japanese encephalitis virus
latent infection
lectin
lipid biosynthesis
LUMS1
lytic gene expression
macacine herpesvirus-1
measles virus
microvirin
mutations
n/a
neural stem cells
NF-κB signaling pathway
non-immunogenic
NS5
nucleic acid-based therapeutic approach
nucleoside analogues
oleanane-type derivatives
orthohantavirus
pediatrics
PEI
persistent infection
phenyl-benzotriazoles
Plantago asiatica
polyethylenimine
Porcine circovirus type 2
porcine reproductive and respiratory syndrome virus
pre-treatment drug resistance
precursor membrane protein
pro-inflammatory factor
prodrugs
protein drugs
ProTides
PRRSV
quantitative real-time PCR
replication
resistance
Rev response element
ribozyme
RNA interference
RNA-dependent RNA polymerase
RSV
sesquiterpene lactone
SHAPE
small molecule
sphingolipids
Surveyor nuclease mutation detection assay
TALEN
therapeutic effects
therapeutic strategies
transferrins
treatments
tropism
viral entry
virion internalization
virus attachment
virus entry inhibitors
viruses
Zika virus
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557448703321
Adamson Catherine  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Nucleic Acid Architectures for Therapeutics, Diagnostics, Devices and Materials / Kirill Afonin
Nucleic Acid Architectures for Therapeutics, Diagnostics, Devices and Materials / Kirill Afonin
Autore Afonin Kirill
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2019
Descrizione fisica 1 electronic resource (186 p.)
Soggetto topico Biology, life sciences
Soggetto non controllato cotranscriptional folding
RNA
conditionally activated
i-motif DNA
spinal cord tumor
fluorescence
dynamic
stability
functional RNA
ribozyme
biological media
RNA aptamers
gene therapy
biosensors
viral vector
ganciclovir
RNA self-assembly
RNA nanoparticle
gene delivery
riboswitch
non-viral gene delivery
NANPs
silver nanoclusters
small-angle neutron scattering
contrast variation
aptamers
RNA logic
fluorogenic RNA
glioblastoma multiforme
RNA interference
nucleic acid nanoparticles
immunostimulation
aggregation
small-angle X-ray scattering
non-viral vector
light-up aptamer
nucleic acid therapeutic
live-cell imaging
DNA nanotechnology
nucleic acid computing
nanopores
structural characterization
siRNA
suicide gene therapy
nucleic acid nanoparticle
cytosine rich sequences
RNA nanotechnology
logic gates
serum
conditional activation
ISBN 9783039212606
3039212605
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910367569503321
Afonin Kirill  
MDPI - Multidisciplinary Digital Publishing Institute, 2019
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui